FAAH and colorectal cancer: Several nonselective and selective inhibitors of FAAH, including URB597, a relatively selective, irreversible, carbamate-based inhibitor, exert potential anticancer effects in ovarian, breast, prostate, and colorectal cancers [38–40], suggesting that targeting FAAH might be a promising anticancer strategy.